Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1586-1591

  Madjlessi Simon, Tabassome ^a   Mary Krause, Murielle ^b   Fillette, Frédéric ^c   Lechat, Philippe ^c   Jaillon, Patrice ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; AMBULATORY MONITORING; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029941021     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00050-2     Document Type: Article

References (30)

1. Reis SE, Gottlieb SO. Prognostic implications of transient asymptomatic myocardial ischemia as detected by ambulatory electrocardiographic monitoring. Prog Cardiovasc Dis 1992;35:77-96.
2. Rocco MB, Nabel EG, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with coronary artery disease. Circulation 1988;78:877-84.
3. Deedwania P, Carbajal E. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-56.
4. Deedwania P, Carbajal E. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise induced myocardial ischemia. Am J Cardiol 1991;68:1279-86.
5. Moss AJ, Goldstein RE, Hall WJ, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA 1993;269:2379-85.
6. Bertolet BD, Hill JA, Pepine CJ. Treatment strategies for daily life silent myocardial ischemia: correlation with potential pathogenic mechanisms. Prog Cardiovasc Dis 1992;35:97-118.
7. Stone PH, Gibson RS, Glasser SP, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990;82:1962-72.
8. Deedwania PC, Carbajal EV, Nelson JR, Hait H. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol 1991;17:963-9.
9. Pepine CJ, Cohn PF, Deedwania PC. et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. Circulation 1994;90:762-8.
10. Knatterud GL, Bourassa MG, Pepine CJ, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994;24:11-20.
11. Madjlessi-Simon T, Fillette F, Mary-Krause M, Lechat P, Jaillon P. Effects of amlodipine on transient myocardial ischemia in severe coronary patients treated with a betablocker. Eur Heart J 1995;16:1780-8.
12. Nabel EG, Barry J, Rocco MB, et al. Variability of transient ischemia in ambulatory patients with coronary artery disease. Circulation 1988;78:60-7.
13. Campbell S, Barry J, Rocco MB, et al. Features of the exercise test reflect the activity of ischemic heart disease out of hospital. Circulation 1986;74:72-80.
14. Mulcahy D, Keegan J, Sparrow J, et al. Ischemia in the ambulatorry setting - the total ischemic burden: relation to exercise testing and investigative and therapeutic implications. J Am Coll Cardiol 1989;14:1166-72.
15. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford: Blackwell Scientific, 1994:469-92.
16. Mancini J, Bourassa MG, Williamson PR, et al. Prognostic importance of quantitative analysis of coronary cineangiograms. Am J Cardiol 1992;69:1022-7.
17. Malmberg K, Bavenholm P, Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 1994;24:592-9.
18. Harris PJ, Phil D, Behar VS, et al. The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease. Circulation 1980;62:240-8.
19. Sanz G, Castaner A, Betrui A, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982;306:1065-70.
20. Proudfit WJ, Bruschke AV, MacMillan JP, Williams GW, Sones FM. Fifteen years survival study of patients with obstructive coronary artery disease. Circulation 1983;68:986-97.
21. Gottlieb SO, Weisfeld ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker of early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214-9.
22. Gill JB, Cairns JA, Roberts RS, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996;334:65-70.
23. Egstrup K. Asymptomatic myocardial ischemia as a predictor of cardiac events after coronary bypass grafting for stable angina pectoris. Am J Cardiol 1988;61:248-52.
24. Yeung AC, Barry J, Orav J, Bonassin E, Raby KE, Selwyn AP. Effects of asymptomatic ischemia on long term prognosis in chronic stable coronary artery disease. Circulation 1991;83:1598-604.
25. Rogers WJ, Bourassa MG, Andrews TC, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995;26:594-605.
26. Miller R, Olson HG, Amsterdam EA, Mason D. Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 1975;293:416-20.
27. Myers MG, Wisenberg G. Sudden withdrawal of propranolol in patients with angina pectoris. Chest 1977;71:24-6.
28. Frischman WH. Beta-adrenergic blocker withdrawal. Am J Cardiol 1987;59: 26F-32F.
29. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction. JAMA 1988;260:2088-93.
30. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Betablockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.